CD8A and neoplasm: CAFs upregulate PD-1, CTLA-4, TIM-3, and LAG-3 expression on both CD8+ and CD4+ T cells, resulting in hampered proliferation of T cells and impaired recognition of tumor cells in pancreatic cancer (39).